Practice question

Answer the question and get instant feedback.

ModerateInfectious DiseasesCDI-Recurrence Riskus-abimus-usmle-step-3

A 58-year-old with nonsevere CDI completed fidaxomicin. Which factor supports considering bezlotoxumab to prevent recurrence in a future episode?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.